Cancer Treatment and Research Communications
Overview
Cancer Treatment and Research Communications is a scientific journal, published by Elsevier since 2016 in English. The journal's country of origin is United Kingdom and its primary focus area is oncology.
Details
Details
Abbr.
Cancer Treat Res Commun
Publisher
Elsevier
Start
2016
End
Continuing
e-ISSN
2468-2942
Country
United Kingdom
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 11752
23
SJR / Ranks: 5339
793
CiteScore / Ranks: 8566
3.00
Recent Articles
11.
Adigun M, Esan D, Oyinloye B, Adeyanju B, Olowoyo K, Olawade D
Cancer Treat Res Commun
. 2025 Feb;
43:100877.
PMID: 39947002
Introduction: Cervical cancer remains a significant public health concern among women globally, with a high burden of morbidity and mortality. Despite the existence of empirical evidence about various preventive strategies,...
12.
Alkhawaldeh I, Al-Jafari M, El Din Moawad M, Alabdallat Y, Shaaban Abdelgalil M, AlQurm A, et al.
Cancer Treat Res Commun
. 2025 Feb;
43:100883.
PMID: 39947001
Background: The current research efforts in the Middle East do not sufficiently capture the full extent of the burden posed by brain tumors in the region. Objective: Our study aimed...
13.
Esmaeili A, Awasthi P, Tabaee S
Cancer Treat Res Commun
. 2025 Feb;
43:100880.
PMID: 39923321
This comprehensive review delves into the intricate role of programmed cell death in Epstein-Barr virus (EBV)-associated malignancies, focusing on the sophisticated interplay between viral mechanisms and the host's immune response....
14.
Sun M, Yu J, Wan J, Dou X, Chen X, Ye F
Cancer Treat Res Commun
. 2025 Feb;
43:100884.
PMID: 39923320
Aspirin [1], also known as acetylsalicylic acid, is a common non-steroidal anti-inflammatory drug (NSAID). The available evidence shows that aspirin can effectively prevent and treat diseases such as rectal, gastric,...
15.
Hasan N, Yazdanpanah O, Khaleghi B, Benjamin D, Kalebasty A
Cancer Treat Res Commun
. 2025 Feb;
43:100876.
PMID: 39922003
Goal Of The Review: The objective of this review is to conduct a thorough examination of the current evidence regarding the correlation between dietary sugar intake and cancer risk. This...
16.
Wang L, Kong Y, Zhang Y, Mu C
Cancer Treat Res Commun
. 2025 Feb;
42:100868.
PMID: 39908681
Objective: This study analyzes the clinical characteristics of ALK-positive lung cancer patients and the impact of PD-L1 expression on their prognosis, providing insights for diagnosis and treatment. Materials And Methods:...
17.
Illini O, Lang-Stoberl A, Fabikan H, Weinlinger C, Valipour A, Hochmair M
Cancer Treat Res Commun
. 2025 Feb;
42:100875.
PMID: 39904276
Introduction: Treatment options for HER2-mutant patients with non-small cell lung cancer (NSCLC) are limited. New agents, including zongertinib, a HER2-selective tyrosine kinase inhibitor (TKI), are being investigated in clinical trials....
18.
Pratama S, Wiyono L, Setiawan M, Lauren B
Cancer Treat Res Commun
. 2025 Feb;
42:100874.
PMID: 39892078
Background: Small Cell Lung Cancer (SCLC) is a neuroendocrine carcinoma characterized by aggressive behavior and poor prognosis with limited treatment options. Poly ADP-Ribose Polymerase inhibitors (PARPi) are novel anti-cancer agents...
19.
Shweikeh F, Zeng Y, Jabir A, Whittenberger E, Kadatane S, Huang Y, et al.
Cancer Treat Res Commun
. 2025 Feb;
42:100872.
PMID: 39892077
Background: Colorectal cancer (CRC), the third most commonly diagnosed and second most lethal cancer worldwide, necessitates efficient early detection strategies to improve patient outcomes. This review evaluates the promise of...
20.
Noguchi N, Boroumand F, Bell K, Pooley M, Zeng A, Arnold L, et al.
Cancer Treat Res Commun
. 2025 Jan;
42:100865.
PMID: 39889334
Purpose: To compare the performance of Digital Breast Tomosynthesis (DBT) with Digital Mammography (DM) in patients clinically referred for breast imaging. Methods: Diagnostic performance of DBT (in 2016, after transition...